This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
IMITREX
GLAXOSMITHKLINE INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of IMITREX in Canada?
Yes. IMITREX 5MG has an active shortage reported to Health Canada (last updated November 4, 2026).
Why is IMITREX not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will IMITREX be available again?
The manufacturer's estimated resolution date is November 20, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02230418
Strength
5MG
Dosage Form
SPRAY
Route
NASAL
Active Ingredient
SUMATRIPTAN
Tier
Unrated
Last Updated
2025-09-12
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
IMITREX has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from GLAXOSMITHKLINE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02245127
DIN 02245126
DIN 02240835
DIN 02240836
DIN 02240837
1MG · DIN 02237820
2.5MG · DIN 02237821
DIN 02418401
120MCG · DIN 02540207
200MCG · DIN 02446588
100MCG · DIN 02446561
27.5MCG · DIN 02298589